Streetbeat News

Revenues

ICU

SeaStar Medical Holding Corporation (NASDAQ:ICU) provided updates on its acute kidney injury (AKI) programs, including the enrollment of 21 subjects in its NEUTRALIZE-AKI clinical trial for adult AKI patients. The trial aims to enroll up to 200 adults to evaluate the safety and efficacy of its Selective Cytopheretic Device (SCD) therapy. Additionally, the FDA granted a Humanitarian Device Exemption Approval Order for its Quelimmune pediatric device for AKI due to sepsis, with plans to expand commercial rollout with Nuwellis, Inc. in Q2. The company also plans a business update conference call in April.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:57 pm

SPY

The Consumer Price Index (CPI) for February showed a year-over-year increase of 3.2%, slightly above the expected 3.1% and the previous month's 3.1%.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:30 pm

SPY

The USA Consumer Price Index (CPI) for February increased by 0.4%, matching the estimated 0.4% and showing a slight increase from the previous month's 0.3%.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:30 pm

BYD

IAS

ROKU

WSC

Insiders at WillScot Mobile Mini, Boyd Gaming, Integral Ad Science Holding, and Roku have recently sold shares. These sales could indicate various strategic decisions or perspectives on the companies' valuations. WillScot Mobile Mini reported disappointing earnings, Boyd Gaming increased its dividend, Integral Ad Science reported strong Q4 results, and Roku showed revenue growth.

Portfolio Pulse from Avi Kapoor

March 12, 2024 | 12:20 pm

BZ

Kanzhun has projected its Q1 revenue to be between RMB1.64 billion and RMB1.67 billion, surpassing the estimated RMB1.599 billion. This correction indicates a positive outlook for the company's financial performance.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:12 pm

PRTH

Priority Technology Holdings' shares surged following the announcement of their Q4 financial results, which exceeded expectations. Additionally, the company provided FY24 revenue guidance that surpassed analyst estimates, indicating a positive outlook for future growth.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:09 pm

ENFN

Enfusion (NYSE:ENFN) reported Q4 2023 adjusted EPS of $0.04, missing the consensus estimate of $0.05 by 20%. However, their sales of $46.486M exceeded the estimate of $45.275M by 2.67%, marking a 14.73% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:05 pm

KBR

Recent analyst reviews on KBR (NYSE:KBR) show a generally bullish outlook, with 6 analysts offering insights over the past three months. The average 12-month price target for KBR is $69.33, marking a 4.73% increase from the previous target of $66.20. Analyst actions include both upgrades and a downgrade, with price targets ranging from $63.00 to $80.00. KBR, a global provider of engineering and construction services, reported a revenue growth of 7.59% and a net margin of 1.21% for the year 2023, indicating strong performance despite some challenges in debt management and return on equity.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 12:02 pm

TRMB

In the last three months, 6 analysts have updated their ratings on Trimble (NASDAQ:TRMB), with a shift towards a more bullish outlook. The average 12-month price target has increased by 15.6% to $63.00. Analysts from firms like Piper Sandler, Baird, and JP Morgan have raised their price targets, reflecting positive market conditions and Trimble's performance. Trimble has shown solid revenue growth of 8.86% as of December 31, 2023, with a net margin of 6.76% and ROE of 1.42%, indicating strong financial health despite a high debt-to-equity ratio of 0.71.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 12:02 pm

JFBR

Jeffs' Brands Ltd (NASDAQ:JFBR, JFBRW), a data-driven e-commerce company, announced preliminary unaudited financial results for its subsidiary, Fort Products Ltd., showing a 23% increase in Amazon Marketplace sales revenue to $5.3M for 2023. The profit from these sales was $614K, up from $445K in 2022. CEO Victor Hakmon highlighted the success since acquiring Fort and plans for future growth.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 12:01 pm